CH505805A - Verfahren zur Herstellung neuer Bisnorcholanderivate - Google Patents

Verfahren zur Herstellung neuer Bisnorcholanderivate

Info

Publication number
CH505805A
CH505805A CH1249269A CH1249269A CH505805A CH 505805 A CH505805 A CH 505805A CH 1249269 A CH1249269 A CH 1249269A CH 1249269 A CH1249269 A CH 1249269A CH 505805 A CH505805 A CH 505805A
Authority
CH
Switzerland
Prior art keywords
bisnorcholane
derivatives
new
production
new bisnorcholane
Prior art date
Application number
CH1249269A
Other languages
English (en)
Inventor
Ferdinand Dr Kuhnen
Mahmod Dr Muftic
Rainer Dr Philippson
Kaspar Emanuel
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH505805A publication Critical patent/CH505805A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH1249269A 1965-09-03 1966-08-30 Verfahren zur Herstellung neuer Bisnorcholanderivate CH505805A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DESC037674 1965-09-03
DESC038090 1965-11-27

Publications (1)

Publication Number Publication Date
CH505805A true CH505805A (de) 1971-04-15

Family

ID=25993310

Family Applications (3)

Application Number Title Priority Date Filing Date
CH1254366A CH504425A (de) 1965-09-03 1966-06-30 Verfahren zur Herstellung neuer Bisnorcholanderivate
CH1249269A CH505805A (de) 1965-09-03 1966-08-30 Verfahren zur Herstellung neuer Bisnorcholanderivate
CH1249169A CH504426A (de) 1965-09-03 1966-08-30 Verfahren zur Herstellung neuer Bisnorcholanderivate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1254366A CH504425A (de) 1965-09-03 1966-06-30 Verfahren zur Herstellung neuer Bisnorcholanderivate

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH1249169A CH504426A (de) 1965-09-03 1966-08-30 Verfahren zur Herstellung neuer Bisnorcholanderivate

Country Status (5)

Country Link
US (1) US3539687A (de)
CH (3) CH504425A (de)
DE (2) DE1493169A1 (de)
GB (1) GB1118976A (de)
NL (1) NL6612348A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4088760A (en) * 1976-06-23 1978-05-09 Richardson-Merrell Inc. Testosterone 5α-reductase inhibitors
DE2839033A1 (de) * 1978-09-05 1980-03-13 Schering Ag 3-oxo-4-pregnen-20 alpha -carbonsaeure- derivate, ihre herstellung und verwendung
AT368759B (de) * 1980-05-12 1982-11-10 Henkel Kgaa Verfahren zur herstellung von neuen steroid-20carbons[ureverbindungen
USRE35053E (en) * 1985-09-12 1995-10-10 The Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
US5382661A (en) * 1985-09-12 1995-01-17 The Upjohn Company Pyrazinylpiperazinyl steroids
US20100048913A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
EP2393827B1 (de) * 2009-02-05 2015-10-07 Tokai Pharmaceuticals, Inc. Neue prodrugs von steroiden cyp17-inhibitoren/antiandrogenen
US9884067B2 (en) 2013-03-14 2018-02-06 University Of Maryland, Baltimore Androgen receptor down-regulating agents and uses thereof
US9808472B2 (en) 2013-08-12 2017-11-07 Tokai Pharmaceuticals, Inc. Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2697107A (en) * 1951-06-20 1954-12-14 Hoechst Ag Process of preparing chloramines of the steroid series
US2886564A (en) * 1955-03-24 1959-05-12 Upjohn Co Quaternary steroidal enamine salts
US3038912A (en) * 1961-07-21 1962-06-12 Searle & Co 20(bets)-[(monoalkylamino)methyl]pregn-5-en-3beta-ols, esters corresponding and intermediates thereto
GB1095167A (en) * 1963-12-05 1967-12-13 Shalom Sarel Amino-steroids

Also Published As

Publication number Publication date
NL6612348A (de) 1967-03-06
US3539687A (en) 1970-11-10
DE1493181A1 (de) 1969-06-26
CH504426A (de) 1971-03-15
CH504425A (de) 1971-03-15
GB1118976A (en) 1968-07-03
DE1493169A1 (de) 1969-06-04

Similar Documents

Publication Publication Date Title
CH513111A (de) Verfahren zur Herstellung neuer Benz-epinderivate
CH474486A (de) Verfahren zur Herstellung neuer Diphenylharnstoffe
CH526579A (de) Verfahren zur Herstellung neuer Benziodoxanderivate
CH505805A (de) Verfahren zur Herstellung neuer Bisnorcholanderivate
AT279636B (de) Verfahren zur Herstellung neuer Benzomorphanderivate
CH519488A (de) Verfahren zur Herstellung neuer 19-Nor-androstatriene
CH476723A (de) Verfahren zur Herstellung neuer Isoindol-Derivate
CH467786A (de) Verfahren zur Herstellung neuer Chinazolin-Derivate
CH467789A (de) Verfahren zur Herstellung neuer Diazepin-Derivate
CH432538A (de) Verfahren zur Herstellung neuer Yohimban-Derivate
CH517737A (de) Verfahren zur Herstellung neuer Spiro-azatetramethylen-Derivate
AT256848B (de) Verfahren zur Herstellung neuer Oxepinderivate
AT256097B (de) Verfahren zur Herstellung neuer Indolderivate
CH467800A (de) Verfahren zur Herstellung neuer Diazepin-Derivate
CH473807A (de) Verfahren zur Herstellung neuer 4-Hydroxy-chinoline
AT310962B (de) Verfahren zur Herstellung neuer 18-Methyl-5α-H-androstan-derivate
CH462834A (de) Verfahren zur Herstellung neuer 6-Hydrazino-pyridazin-Derivate
CH464935A (de) Verfahren zur Herstellung neuer Chinazolinonderivate
CH467779A (de) Verfahren zur Herstellung neuer Indol-Derivate
CH468386A (de) Verfahren zur Herstellung neuer Ergolen-Derivate
AT261819B (de) Verfahren zur Herstellung neuer Gonanderivate
CH467793A (de) Verfahren zur Herstellung neuer Ergolen-Derivate
AT266106B (de) Verfahren zur Herstellung neuer Nitrofuranderivate
AT243813B (de) Verfahren zur Herstellung neuer Azepinderivate
CH451924A (de) Verfahren zur Herstellung neuer Indanderivate

Legal Events

Date Code Title Description
PL Patent ceased